| Application no. and date | 10808442.7 (espacenet) (Federated) (European Patent Register), 20100809 | | Patent/reg. no. and date | DK/EP 2467372, 20160518 | | Publication date | 20120627 | | Priority no. and date | US 273920 P, 20090810 | | EP pub. no. and date |
EP 2467372 20120627 | | Effective date | | | Applicant/owner | Active Biotech AB, Scheelevägen 22
P.O. Box 724
S-220 07 Lund, SE | | Applicant ref. no. | P59365DK01 | | Inventor | HAYARDENY, Liat, 37 Yehuda Hanasie St.
Tel Aviv 69391, IL | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/138 (2006.01) , A61K 31/428 (2006.01) , A61K 31/4704 (2006.01) , A61P 25/00 (2006.01) , A61P 25/16 (2006.01) , A61P 25/18 (2006.01) , A61P 25/22 (2006.01) , A61P 25/24 (2006.01) , A61P 25/28 (2006.01) | | Title | BEHANDLING AF BDNF-RELATEREDE LIDELSER UNDER ANVENDELSE AF LAQUINIMOD | | Int. application no. | US2010002194 | | Int. publication no. | WO2011019375 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
